GlassScriptPhysician profile
Amarjit Dosanjh
NPI 1194857615
$1,380.15
in general payments reported to CMS, 2019-2025
14 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.85 · 2020: $74.22 · 2021: $421 · 2022: $108 · 2023: $160 · 2024: $272 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $290.05 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Sientra, INC. | $211.35 | 2019-2021 | |
| Mentor Worldwide LLC | $147.98 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $143.70 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $120.25 | 2019-2024 | |
| Coopersurgical, INC. | $115.01 | 2025 | Onetrac Lx |
| Depuy Synthes Sales INC. | $112.59 | 2021 | |
| Organogenesis INC. | $108.25 | 2022 | |
| Stryker Corporation | $37.49 | 2020 | |
| Polarityte, INC. | $27.70 | 2019 | |
| Acera Surgical, INC. | $20.78 | 2024 | Restrata Wound Matrix |
| Acell, INC. | $18.84 | 2019 | |
| Sanara Medtech INC. | $13.30 | 2023 | Celleraterx |
| Allergan, INC. | $12.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amarjit Dosanjh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.